Both CXCR2P1 and NCF1Care are good prognosis-related lncRNAs in the IMvigor210 cohort, and both of them show a function in the regulation of immune-related genes in the TCGA-BLCA, but both of them were not associated with survival. The gene discussed is CXCR2P1; the disease is bladder transitional cell carcinoma.